Anderson-Fabry's disease: neuropathological and neurochemical investigation.
A clinical, neuropathological and neurochemical study of a case of Anderson-Fabry's disease is described. The clinical course mainly consisted of repeated ictus with major involvement of the CNS. The neuropathological examination is dominated by severe alterations in the cerebral vessels due to glycolipid deposits on the walls, with reduction or occlusion of the lumen. This is correlated with secondary ischaemic foci scattered throughout the cortex as well as through the white matter. In addition, the cells of the cerebral cortex, thalamus, basal ganglia, amygdala, cerebellar and olivary nuclei show a marked accumulation of lipofuscin. Biochemical examination reveals a threefold increase in galactolipids due to the specific alpha-galactosidase deficiency. Cholesterol is reduced secondarily to ischaemic myelin damage. Glycosaminoglycans uronic acid is increased in cytosol and membrane-bound fractions which could be related to reactive gliosis. Glycoprotein sugars show a decrease in N-acetyl-neuraminic acid and fucose as well as an increase in hexosamines and hexoses in membrane-bound fraction, while in cytosol fraction all sugars are increased. This suggests that the alpha-galactosidase deficiency can alter not only the glycolipid but also the glycoprotein metabolism, resulting in a higher presence of hexosamines and hexoses-rich glycoproteins.
D000679:Amygdala / Q000473:pathology; D001479:Basal Ganglia / Q000473:pathology; D001808:Blood Vessels / Q000473:pathology; D001921:Brain / Q000098:blood supply; D002529:Cerebellar Nuclei / Q000473:pathology; D002540:Cerebral Cortex / Q000473:pathology; D000795:Fabry Disease; D005696:Galactosidases / Q000172:deficiency*; D006017:Glycolipids / Q000378:metabolism*; D006801:Humans; D008052:Lipid Metabolism, Inborn Errors / Q000473:pathology*; D008297:Male; D008875:Middle Aged; D013788:Thalamus / Q000473:pathology
D006017:Glycolipids; D005696:Galactosidases